Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes

Research output: Contribution to journal › Letter › Research › peer-review

Standard

Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes. / Rhee, Nicolai A; Wahlgren, Camilla D; Pedersen, Jens; Mortensen, Brynjulf; Langholz, Ebbe; Wandall, Erik P; Friis, Steffen U; Vilmann, Peter; Paulsen, Sarah J; Kristiansen, Viggo B; Jelsing, Jacob; Dalbøge, Louise S; Poulsen, Steen S; Holst, Jens J; Vilsbøll, Tina; Knop, Filip K.

In: Diabetologia, Vol. 58, No. 10, 2015, p. 2254-2258.

Research output: Contribution to journal › Letter › Research › peer-review

Harvard

Rhee, NA, Wahlgren, CD, Pedersen, J, Mortensen, B, Langholz, E, Wandall, EP, Friis, SU, Vilmann, P, Paulsen, SJ, Kristiansen, VB, Jelsing, J, Dalbøge, LS, Poulsen, SS, Holst, JJ, Vilsbøll, T & Knop, FK 2015, 'Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes', Diabetologia, vol. 58, no. 10, pp. 2254-2258. https://doi.org/10.1007/s00125-015-3696-3

APA

Rhee, N. A., Wahlgren, C. D., Pedersen, J., Mortensen, B., Langholz, E., Wandall, E. P., Friis, S. U., Vilmann, P., Paulsen, S. J., Kristiansen, V. B., Jelsing, J., Dalbøge, L. S., Poulsen, S. S., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2015). Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes. Diabetologia, 58(10), 2254-2258. https://doi.org/10.1007/s00125-015-3696-3

Vancouver

Rhee NA, Wahlgren CD, Pedersen J, Mortensen B, Langholz E, Wandall EP et al. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes. Diabetologia. 2015;58(10):2254-2258. https://doi.org/10.1007/s00125-015-3696-3

Author

Rhee, Nicolai A ; Wahlgren, Camilla D ; Pedersen, Jens ; Mortensen, Brynjulf ; Langholz, Ebbe ; Wandall, Erik P ; Friis, Steffen U ; Vilmann, Peter ; Paulsen, Sarah J ; Kristiansen, Viggo B ; Jelsing, Jacob ; Dalbøge, Louise S ; Poulsen, Steen S ; Holst, Jens J ; Vilsbøll, Tina ; Knop, Filip K. / Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes. In: Diabetologia. 2015 ; Vol. 58, No. 10. pp. 2254-2258.

Bibtex

@article{26fffeba09894267b89e3f223458e1f9,
title = "Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes",
abstract = "AIMS/HYPOTHESIS: We studied the impact of Roux-en-Y gastric bypass (RYGB) on the density and hormonal gene expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.METHODS: Twelve patients with diabetes and 11 age- and BMI-matched controls underwent RYGB followed by enteroscopy ~10 months later. Mucosal biopsies taken during surgery and enteroscopy were immunohistochemically stained for glucagon-like peptide-1 (GLP-1), peptide YY (PYY), cholecystokinin (CCK), glucose-dependent insulinotropic polypeptide (GIP) and prohormone convertase 2 (PC2) and the expression of GCG (encoding preproglucagon), PYY, CCK, GIP, GHRL (encoding ghrelin), SCT (encoding secretin), NTS (encoding neurotensin) and NR1H4 (encoding farnesoid X receptor) was evaluated.RESULTS: The density of cells immunoreactive for GLP-1, CCK and GIP increased in patients after RYGB and the density of those immunoreactive for GLP-1, PYY, CCK and PC2 increased in controls. In both groups, GHRL, SCT and GIP mRNA was reduced after RYGB while PYY, CCK, NTS and NR1H4 gene expression was unaltered. GCG mRNA was upregulated in both groups.CONCLUSIONS/INTERPRETATION: Numerous alterations in the distribution of enteroendocrine cells and their expression of hormonal genes are seen after RYGB and include increased density of GLP-1-, PYY-, CCK-, GIP- and PC2-positive cells, reduced gene expression of GHRL, SCT and GIP and increased expression of GCG.",
author = "Rhee, {Nicolai A} and Wahlgren, {Camilla D} and Jens Pedersen and Brynjulf Mortensen and Ebbe Langholz and Wandall, {Erik P} and Friis, {Steffen U} and Peter Vilmann and Paulsen, {Sarah J} and Kristiansen, {Viggo B} and Jacob Jelsing and Dalb{\o}ge, {Louise S} and Poulsen, {Steen S} and Holst, {Jens J} and Tina Vilsb{\o}ll and Knop, {Filip K}",
year = "2015",
doi = "10.1007/s00125-015-3696-3",
language = "English",
volume = "58",
pages = "2254--2258",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "10",

}

RIS

TY - JOUR

T1 - Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes

AU - Rhee, Nicolai A

AU - Wahlgren, Camilla D

AU - Pedersen, Jens

AU - Mortensen, Brynjulf

AU - Langholz, Ebbe

AU - Wandall, Erik P

AU - Friis, Steffen U

AU - Vilmann, Peter

AU - Paulsen, Sarah J

AU - Kristiansen, Viggo B

AU - Jelsing, Jacob

AU - Dalbøge, Louise S

AU - Poulsen, Steen S

AU - Holst, Jens J

AU - Vilsbøll, Tina

AU - Knop, Filip K

PY - 2015

Y1 - 2015

N2 - AIMS/HYPOTHESIS: We studied the impact of Roux-en-Y gastric bypass (RYGB) on the density and hormonal gene expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.METHODS: Twelve patients with diabetes and 11 age- and BMI-matched controls underwent RYGB followed by enteroscopy ~10 months later. Mucosal biopsies taken during surgery and enteroscopy were immunohistochemically stained for glucagon-like peptide-1 (GLP-1), peptide YY (PYY), cholecystokinin (CCK), glucose-dependent insulinotropic polypeptide (GIP) and prohormone convertase 2 (PC2) and the expression of GCG (encoding preproglucagon), PYY, CCK, GIP, GHRL (encoding ghrelin), SCT (encoding secretin), NTS (encoding neurotensin) and NR1H4 (encoding farnesoid X receptor) was evaluated.RESULTS: The density of cells immunoreactive for GLP-1, CCK and GIP increased in patients after RYGB and the density of those immunoreactive for GLP-1, PYY, CCK and PC2 increased in controls. In both groups, GHRL, SCT and GIP mRNA was reduced after RYGB while PYY, CCK, NTS and NR1H4 gene expression was unaltered. GCG mRNA was upregulated in both groups.CONCLUSIONS/INTERPRETATION: Numerous alterations in the distribution of enteroendocrine cells and their expression of hormonal genes are seen after RYGB and include increased density of GLP-1-, PYY-, CCK-, GIP- and PC2-positive cells, reduced gene expression of GHRL, SCT and GIP and increased expression of GCG.

AB - AIMS/HYPOTHESIS: We studied the impact of Roux-en-Y gastric bypass (RYGB) on the density and hormonal gene expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.METHODS: Twelve patients with diabetes and 11 age- and BMI-matched controls underwent RYGB followed by enteroscopy ~10 months later. Mucosal biopsies taken during surgery and enteroscopy were immunohistochemically stained for glucagon-like peptide-1 (GLP-1), peptide YY (PYY), cholecystokinin (CCK), glucose-dependent insulinotropic polypeptide (GIP) and prohormone convertase 2 (PC2) and the expression of GCG (encoding preproglucagon), PYY, CCK, GIP, GHRL (encoding ghrelin), SCT (encoding secretin), NTS (encoding neurotensin) and NR1H4 (encoding farnesoid X receptor) was evaluated.RESULTS: The density of cells immunoreactive for GLP-1, CCK and GIP increased in patients after RYGB and the density of those immunoreactive for GLP-1, PYY, CCK and PC2 increased in controls. In both groups, GHRL, SCT and GIP mRNA was reduced after RYGB while PYY, CCK, NTS and NR1H4 gene expression was unaltered. GCG mRNA was upregulated in both groups.CONCLUSIONS/INTERPRETATION: Numerous alterations in the distribution of enteroendocrine cells and their expression of hormonal genes are seen after RYGB and include increased density of GLP-1-, PYY-, CCK-, GIP- and PC2-positive cells, reduced gene expression of GHRL, SCT and GIP and increased expression of GCG.

U2 - 10.1007/s00125-015-3696-3

DO - 10.1007/s00125-015-3696-3

M3 - Letter

C2 - 26186884

VL - 58

SP - 2254

EP - 2258

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 10

ER -

ID: 150709021